EMA Authorised: Fingolimod Accord (fingolimod hydrochloride) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA authorised Fingolimod Accord (fingolimod hydrochloride) from Accord Healthcare S.L.U. for relapsing-remitting multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Fingolimod Accord (fingolimod hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Multiple Sclerosis, Relapsing-Remitting. MAH: Accord Healthcare S.L.U.. Decision date: 05/05/2025